CASI Pharmaceuticals to Participate at Guggenheim Healthcare Innovation Conference

November 4, 2025 9:00 AM

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company focused on developing CID-103, a potential best-in-class, anti-CD38 monoclonal antibody for patients with organ transplant rejection and autoimmune diseases, today announced that the CASI management team will participate at the Guggenheim Healthcare Innovation Conference 2025 in a fireside chat at 9:30 AM ET on November 12 in Boston, MA. CASI will also host...

Read more

Merck KGaA, Darmstadt, Germany Signs Long-Term Renewable Energy Contract for South Korea Sites

November 4, 2025 9:00 AM

Merck KGaA, Darmstadt, Germany, a leading science and technology company, has signed a 20-year Power Purchase Agreement (PPA) with SK Innovation E&S to deliver 16 megawatts (MW) of new renewable electricity capacity for its Life Science sites in Daejeon and Songdo, South Korea. This PPA is the company's longest renewable energy commitment in APAC and underscores its focus on leadership in manufacturing sustainability as a driver of business...

Read more

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results

November 4, 2025 8:56 AM

Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announced financial results for its second fiscal quarter ended September 30, 2025."We are thrilled to report the highest...

Read more

VSee Health Secures Three-Year Platform Services Agreement with the Region's Sole Level 1 Trauma Center and Academic Health System

November 4, 2025 8:08 AM

VSee Health, Inc. (NASDAQ:VSEE) has executed a three-year platform services agreement to deliver virtual urgent care and virtual behavioral health services to a leading non-profit academic health system. The contract is structured on a volume-based, invoice-only model with no upper limit on reimbursable services, enabling scalable revenue tied directly to utilization across the health system's network of more than 100 hospitals, outpatient...

Read more

Tampa Bay Hosts the Southeast’s Largest Alternative Wellness Gathering

November 4, 2025 8:00 AM

Tampa Bay is officially emerging as the Southeast's epicenter for innovation in mental health, plant medicine, and integrative wellness. On November 9, 2025, the region will host the Cannadelic Global Summit - the largest alternative wellness and psychedelic education gathering in the Southeastern United States.Held at 2201 1st Ave S in St. Petersburg, Cannadelic Global brings together the nation's leading clinicians, researchers, policy...

Read more

Ignite Biomedical and Liquid Biosciences Announce the Discovery of Biomarkers for the Diagnosis and Treatment of Autism Spectrum Disorder

November 4, 2025 8:00 AM

Ignite Biomedical, Inc. ("Ignite"), a leader in AI-driven biomarker innovation for precision medicine, along with Liquid Biosciences ("Liquid"), today announced the discovery of biomarkers to diagnose and treat autism spectrum disorder ("ASD"). This achievement commences Ignite's expansion into drug development, while also maintaining their focus on diagnostic and treatment predictor tests in areas with tremendous unmet needs."We're incredibly...

Read more

Neurodivergent Empowerment Institute Partners with Cannadelic to Advance Inclusive Mental Wellness

November 4, 2025 6:30 AM

The Neurodivergent Empowerment Institute (NEI), the national clinical + educational division of Bionic Bloom, announces its strategic partnership with Cannadelic Global - marking a significant advancement in the psychedelic field's commitment to inclusivity, accessibility, and trauma-informed mental health.As neurodivergent individuals increasingly seek psychedelic-assisted care and alternative healing pathways, the demand for safer, more...

Read more

Coalition for Patient Rights Announces Update on Their Inaugural Hoedown Nov. 15; Lead-Up Performance by Country Artist Jonny Hazard at Downtown Container Park Nov. 5

November 4, 2025 6:00 AM

The Compassion Center's Coalition for Patient Rights (CPR) reminds everyone about its Inaugural Hoedown on Saturday, Nov. 15, 2025, from 10 a.m. to dusk at Paradise Recreation Center (4775 McLeod Dr., Las Vegas, NV 89121), a community event blending live music, family activities, and patient-rights education with a holiday toy drive for Operation Warm Heart supporting local service members and their families at Nellis and Creech Air Force Bases....

Read more

Equitech-Bio Extends Global Reach With Bioz Badges, Showcasing Citation Engagement From Researchers

November 4, 2025 5:00 AM

Bioz, Inc., the leader in turning scientific literature into actionable product validation, is proud to announce its collaboration with Equitech-Bio, a trusted supplier of serum proteins and critical reagents for life science research and bioprocessing. By embedding Bioz Badges across its digital catalog, Equitech-Bio is bringing real-time, peer-reviewed citation evidence directly to product webpages, helping scientists worldwide evaluate faster...

Read more

BioNxt Reports "Intention to Grant" Patent Notification from the European Patent Office for Its Oral Cladribine Sublingual Thin-Film as the Multiple Sclerosis Market Shifts Toward Patient-Friendly Therapies

November 4, 2025 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to announce that its wholly owned German subsidiary, Vektor Pharma TF GmbH, has received an "Intention to Grant" notification from the European Patent Office (EPO) for European patent application no. 23 729 446.7, covering a sublingual, orally dispersible thin-film formulation of cladribine for the treatment of multiple sclerosis (MS) and related...

Read more

Cellbxhealth PLC Announces Expert Consensus on CTCs; Update on Funding

November 4, 2025 2:00 AM

CELLBXHEALTH plc (AIM:CLBX)(OTCQX:ANPCY), a global leader in circulating tumour cell (CTC) intelligence, welcomes the publication of a major international expert consensus confirming the growing clinical relevance of CTC analysis in cancer management. The study, titled "International expert consensus on the clinical integration of circulating tumor cells in solid tumors", and published in the high-impact factor journal the European Journal of...

Read more

Zealthy Emerges as Digital Health Leader Through Comprehensive Telemedicine Platform

November 3, 2025 7:30 PM

In 2022, Zealthy Founder and CEO Kyle Robertson launched Zealthy with a clear mission: make high-quality healthcare more accessible and affordable for everyone. He had already built his prior telehealth venture, mental health unicorn Cerebral, from zero to nearly a million patients, and was prepared to build something at even greater scale and with a focus on positive impact. In under 2 years, the New York-based company has grown into a 50 state...

Read more

Protagonist Therapeutics Announces Oral and Poster Presentations on Rusfertide at the 67th Annual ASH Meeting

November 3, 2025 4:05 PM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that clinical data on rusfertide in polycythemia vera, including the Phase 3 VERIFY study, will be the focus of four presentations at the 67th Annual American Society of Hematology (ASH) Annual Meeting being held in Orlando, Florida, from December 6-9, 2025.ASH Presentation Details:Presenting Author: Andrew Kuykendall, MD (Moffitt Cancer Center)Publication Number: 81Title:...

Read more

Neuro Energizer Reviews (Urgent Report) Experts Reveal the Truth Behind This 7-Second Genius Bridge Brainwave Audio Program

November 3, 2025 3:15 PM

In 2025, digital wellness has shifted from supplements and wearables to sound-based programs promising mental clarity without chemicals or complex routines. Among them, Neuro Energizer has become a top-searched name on Google, drawing interest from students, professionals, and entrepreneurs seeking a fast yet non-clinical way to boost focus and creativity. Its claim is simple but bold: a 7-Second Audio Sequence That Allegedly Activates The...

Read more

AppaNail Reviews (Urgent Report) Consumer Complaints, Ingredients, and What Doctors Reveal About Side Effects in 2025

November 3, 2025 1:45 PM

Nail health may seem like a cosmetic concern, but in 2025 it's rapidly becoming a recognized indicator of deeper systemic wellness. Persistent brittleness, discoloration, or recurring fungal infections can signal more than surface-level damage, they often reflect nutritional imbalances, compromised immunity, or microbial overgrowth. That's precisely why The Original AppaNail, a natural supplement rooted in Appalachian herbal medicine, is...

Read more

The Assistance Fund Opens New Program for Macular Telangiectasia

November 3, 2025 1:00 PM

The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new financial assistance program for people living with macular telangiectasia (MacTel). The program is designed to help eligible individuals pay for their out-of-pocket medical costs for treatment, such as copays, health insurance premiums, and incidental medical...

Read more

Reprieve House Opens Silicon Valley's First Premium Detox Facility

November 3, 2025 12:00 PM

Reprieve House has opened its doors as Silicon Valley's first and only premium detox facility. The new physician-led detox residence in Los Altos Hills is designed for high-visibility individuals requiring privacy and agency in recovery. Reprieve House provides a discreet, residential option for those seeking support without the exposure or intensity of traditional rehab.Founded to fill a critical gap in the region's behavioral health landscape,...

Read more

Medical Care Technologies, Inc (OTC PINK:MDCE) Announces Development of AI-Powered Wellness App Suite with Global Reach

November 3, 2025 9:30 AM

Medical Care Technologies, Inc. (OTC Pink:MDCE) is excited to announce the development of its upcoming suite of consumer wellness applications. These AI-driven tools will provide innovative and user-friendly wellness insights, allowing individuals to take charge of their health in a non-clinical and accessible manner. In fact, by focusing on wellness-first solutions in a global wellness app market valued at over $10 billion and growing rapidly,...

Read more

CASI Pharmaceuticals Announces Upcoming Presentation of Clinical Results for CID-103 at the 67th American Society of Hematology (ASH) Annual Meeting

November 3, 2025 9:01 AM

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company developing CID-103, a potential best-in-class, clinical stage anti-CD38 monoclonal antibody, for patients with organ transplant rejection and autoimmune diseases, today announced that data will be presented from its Phase 1 open-label study of CID-103 in adult patients with immune thrombocytopenia (ITP) at the 67th American Society of Hematology Annual Meeting...

Read more

Nomination Committee for Senzime Annual General Meeting 2026

November 3, 2025 9:00 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - A Nomination Committee consisting of shareholder representatives has been established for Senzime AB (publ.) in accordance with the principles adopted by the annual general meeting held on May 19, 2025.Members of the Nomination Committee are:Adam Dahlberg, representing the Crafoord family and Crafoord FoundationGabriel Urwitz, representing Segulah AB, Segulah Venture and Segulah Medical AccelerationFredrik...

Read more